29Jul
National Retailer Pulls CBD Products From Shelves in Response to FDA Warning to Product Manufacturer
On Monday, July 22, the U.S. Food and Drug Administration (FDA) took a rare and significant step in issuing a warning letter to Curaleaf Holdings, Inc. (Curaleaf), one of the country’s larger producers of CBD-based products, regarding Curaleaf’s...
By:
Manatt, Phelps & Phillips, LLP
Related
With Independence Day nearly upon us (and with many offices on skeleton crews this week), I thought ...
Read More >
The required minimum distribution rule for both qualified plans and individual retirement accounts i...
Read More >
The California Supreme Court announced that it would decide whether its April 30, 2018 landmark Dyna...
Read More >
News about severe financial difficulties at the Brattleboro Retreat quickly spread throughout the St...
Read More >
When considering whether to acquire a business through an asset sale, it is important for the purcha...
Read More >
The U.S. District Court for the Eastern District of California recently ruled in an employment class...
Read More >